Docosahexaenoic acid modulates in vitro the inflammation of celiac disease in intestinal epithelial cells via the inhibition of cPLA 2

Clinical Nutrition

Volumn 30, Issue 4, 2011, Pages 541-546

  Vincentini, Olimpia ^a   Quaranta, Maria Giovanna ^a   Viora, Marina ^a   Agostoni, Carlo ^b   Silano, Marco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Arachidonic acid; Celiac disease; DHA; Intestinal epithelial cells; Mucosal inflammation

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; DOCOSAHEXAENOIC ACID; GLIADIN; INTERLEUKIN 8; PROSTAGLANDIN E2;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELIAC DISEASE; CELL STRAIN CACO 2; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; MUCOSA INFLAMMATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; UPREGULATION;

ARACHIDONIC ACID; BLOTTING, WESTERN; CACO-2 CELLS; CELIAC DISEASE; CYCLOOXYGENASE 2; DINOPROSTONE; DOCOSAHEXAENOIC ACIDS; DOWN-REGULATION; EPITHELIAL CELLS; GLIADIN; HUMANS; INFLAMMATION; INTERLEUKIN-8; INTESTINES; PEPTIDE FRAGMENTS; PHOSPHOLIPASES A2, CYTOSOLIC;

EID: 79960699348     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.02.007     Document Type: Article

References (36)

1. Koning F., Schuppan D., Cerf-Bensussan N., Sollid L.M. Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol 2005, 19:373-387.
2. Green P.H., Jabri B. Coeliac disease. Lancet 2003, 362:383-391.
3. Jabri B., Kasarda D.D., Green P.H. Innate and adaptive immunity: the yin and yang of celiac disease. Immunol Rev 2005, 206:219-231.
4. Sollid L.M. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002, 2:647-655.
5. Malamut G.R., El Machhour N., Montcuquet S., Martin-Lannerée S., Dusanter-Fourt I., Verkarre V., et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 2010, 120:2131-2143.
6. Meresse B.Z., Chen C., Ciszewski Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21:357-366.
7. Tang F., Chen C., Ciszewski M., Tang F., Chen Z., Ciszewski C., et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med 2009, 206:707-719.
8. Luciani A., Villella V.R., Vasaturo A., Giardino I., Pettoello-Mantovani M., Guido S., et al. Lysosomal accumulation of gliadin p31-43 p.ptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa. Gut 2010, 59:311-319.
9. Martín-Venegas R., Roig-Pérez S., Ferrer R., Moreno J. Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation. J Lipid Res 2006, 47:1416-1423.
10. Kominsky D.J., Campbell E.L., Colgan S.P. Metabolic shift in immunity and inflammation. J Immunol 2010, 184:4062-4068.
11. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008, 52:885-897.
12. Saedisomeolia A., Wood L., Garg M., Gibson P., Wark P. Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells. Br J Nutr 2009, 101:533-540.
13. Martin R. Docosahexaenoic acid decreases phospholipase A2 activity in the neurites/nerve growth cones of PC12 cells. J Neurosci Res 1998, 54:805-813.
14. Freedman S., Blanco P., Zaman M., Shea J.C., Ollero M., Hopper I.K., et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004, 350:560-569.
15. Marion-Letellier R., Butler M., Déchelotte P., Playford R., Ghosh S. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells-potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation. Am J Clin Nutr 2008, 87:939-948.
16. Vachon P.H., Beaulieu J.F. Transient mosaic patterns of morphological and functional differentiation in Caco-2 cell line. Gastroenterology 1991, 103:414-423.
17. De Ritis G., Occorsio P., Auricchio S., Gramenzi F., Morisi G., Silano V. Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus. Pediatr Res 1979, 13:1255-1261.
18. De Angelis I., Vincentini O., Brambilla G., Stammati A., Zucco F. Characterization of furazolidone apical relative effect to human polarized intestinal cell line. Toxicol Appl Pharmacol 1998, 152:119-127.
19. Gentile L.B., Piva B., Capizzani B.C., Furlaneto L.G., Moreira L.S., Zamith-Miranda D., et al. Hypertonic environment elicits cyclooxygenase-2-driven prostaglandin E2 generation by colon cancer cells: role of cytosolic phospholipase A2-alpha and kinase signaling pathways. Prostaglandins Leukot Essent Fatty Acids 2010, 82:131-139.
20. Arranz E., Garrote J.A. Novel mechanism of gliadin immunotoxicity?. Gut 2010, 59:286-287.
21. Barone M.V., Gimigliano A., Castoria G., Paolella G., Maurano F., Paparo F., et al. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 2007, 56:480-488.
22. Silano M., Volta U., Mecchia A.M., Dessì M., Di Benedetto R., De Vincenzi M. Collaborating centers of the Italian registry of the complications of coeliac disease. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol 2007, 7:8.
23. Lavö B., Knutson L., Lööf L., Hällgren R. Gliadin challenge-induced jejunal prostaglandin E2 secretion in celiac disease. Gastroenterology 1990, 99:703-707.
24. Branski D., Hurvitz H., Halevi A., Klar A., Navon P., Weidenfeld J. Eicosanoids content in small intestinal mucosa of children with celiac disease. J Pediatr Gastroenterol Nutr 1992 Feb, 14(2):173-176.
25. Dey I., Giembycz M.A., Chadee K. Prostaglandin E2 couples through EP4 prostanoid receptors to induce IL-8 p.oduction in human colonic epithelial cell lines. Br J Pharmacol 2009, 156:475-486.
26. Hall R.P., Benbenisty K.M., Mickle C., Takeuchi F., Streilein R.D. Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten. J Invest Dermatol 2007, 127:2158-2165.
27. Su C.G., Wen X., Bailey S.T., Jang W., Rangala S.M., Keilbaugh S.A., et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999, 104:383-389.
28. Luciani A., Villella V.R., Vasaturo A., Giardino I., Raia V., Pettoello-Mantovani M., et al. SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J Immunol 2009, 183:2775-2784.
29. Maiuri L., Luciani A., Giardino I., Raia V., Villella V.R., D'Apolito M., et al. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J Immunol 2008, 180:7697-7705.
30. Steel D.M., Ryd W., Ascher H., Strandvik B. Abnormal fatty acid pattern in intestinal mucosa of children with celiac disease is not reflected in serum phospholipids. J Pediatr Gastroenterol Nutr 2006, 43:318-323.
31. Van Biervliet S., Devos M., Delhaye T., Van Biervliet J.P., Robberecht E., Christophe A. Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients. Prostaglandins Leukot Essent Fatty Acids 2008, 78:109-115.
32. Al-Turkmani M.R., Andersson C., Alturkmani R., Katrangi W., Cluette-Brown J.E., Freedman S.D., et al. Mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA. J Lipid Res 2008, 49:1946-1954.
33. Norris J.M., Yin X., Lamb M.M., Barriga K., Seifert J., Hoffman M., et al. Omega-3 p.lyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 2007, 298:1420-1428.
34. Solakivi T., Kaukinen K., Kunnas T., Lehtimäki T., Mäki M., Nikkari S.T. Serum fatty acid profile in celiac disease patients before and after a gluten-free diet. Scand J Gastroenterol 2009, 44:826-830.
35. Shoji H., Franke C., Demmelmair H., Koletzko B. Effect of docosahexaenoic acid on oxidative stress in placental trophoblast cells. Early Hum Dev 2009, 85:433-437.
36. De Palma G., Cinova J., Stepankova R., Tuckova L., Sanz Y. Pivotal advance: bifidobacteria and gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J Leukoc Biol 2010, 87:765-778.